Breaking News, Promotions & Moves

Savara Promotes Dr. Yasmine Wasfi to Chief Medical Officer

Wasfi is a seasoned professional within clinical research and drug development of both large and small molecule novel therapeutics.

Author Image

By: Charlie Sternberg

Associate Editor

Savara Inc., a clinical stage biopharmaceutical company focused on rare respiratory diseases, has promoted Yasmine Wasfi, M.D., Ph.D., FCCP to CMO, effective immediately. She succeeds Ray Pratt, M.D., FACP who will transition from his current role to Senior Medical Advisor. Wasfi will report directly to the Company’s Chair and Chief Executive Officer and will serve as a member of the executive leadership team. Previously, she was Executive Vice President, Head of Clinical Development and Clin...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters